Salarius Pharmaceuticals, Inc. (SLRX) Misses Q1 EPS by 212c
Tweet
Share
E-mailGet Alerts SLRX Hot Sheet
Join SI Premium – FREE
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) reported Q1 EPS of ($2.23), $2.12 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Salarius Pharmaceuticals, Inc. (SLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
